RB homepage

healthcare quality imaging appropriateness clinical decision support CDS checklist

CMS explains how IR specialists can submit prior authorization requests to the federal payment program for seniors, including what evidence is required. 

Artificial intelligence can help make breast cancer screening mammography more accurate.

The number of women who had a screening mammogram miss cancer leapt from less than 1 per 1,000 women in 2010 up to as high as 2.5 by 2022.

Performing an ultrasound

Utilizing both exams provides greater anatomic detail than using one or the other alone. Doing so could significantly improve patient outcomes, experts charge. 

Pre-operative breast MRI improves outcomes in younger women with breast cancer

Advanced imaging among this patient population could help radiologists better understand the risk of potential cancer recurrence. 

The treatment can offer patients a more potent, cost-effective alternative providing long-lasting relief compared to current pain regimens.

Anthem

“When you thought insurers couldn’t get more evil, they come up with something even worse than you anticipated,” one physician said. 

Innovation at work

Six years ago, two radiologists with dissimilar backgrounds and divergent clinical interests put their heads together and launched a new practice. One physician was an academic subspecialized in musculoskeletal reads. The other, a private practitioner, concentrated on oncologic imaging. That’s how Transparent Imaging was born, powered by Konica Minolta. 

Sponsored by Konica Minolta

In a private dining room in Miami, something unusual is happening. Leaders from competing imaging centers are openly discussing their best practices—even sharing vendor recommendations and operational strategies that have doubled their volumes while cutting costs in half.

In cooperation with AbbaDox

Around the web

A growing number of private insurers are now covering these advanced technologies. Roosha Parikh, MD, told Cardiovascular Business that the hard work of SCCT and other groups has helped make this happen. 

Customers are urged to stop using these devices right away.

Researchers used AI-enabled software developed by Cleerly to evaluate the CCTA results of more than 6,000 patients. The software was consistently effective, identifying patients who may face an increased risk of poor outcomes.